Dupixent 00024-5918

Generic: Dupilumab

Product NDC

00024-5918

Manufacturer: Sanofi-Aventis U.s. Llc
Dosage Form: Injection, Solution
Route: Subcutaneous
Product Type: Human Prescription Drug
Marketing Start: October 19, 2018
Listing Expires: December 31, 2027
Application: BLA761055

Need to source Dupixent? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Dupilumab	200 mg/1.14mL

Drug Class

Interleukin-4 Receptor alpha Antagonist [EPC]AntibodiesMonoclonal [CS]

Packaging Options(2)

00024-5918-01

2 SYRINGE, GLASS in 1 CARTON (0024-5918-01) / 1.14 mL in 1 SYRINGE, GLASS (0024-5918-00)

View →

00024-5918-02

2 SYRINGE, GLASS in 1 CARTON (0024-5918-02) / 1.14 mL in 1 SYRINGE, GLASS (0024-5918-20)

View →